Compound Profile: SOMATROPIN 191aa
Somatropin 191aa is a recombinant human growth hormone compound produced through advanced biotechnology processes. This laboratory-grade preparation from CanadaBioLabs contains the complete 191 amino acid sequence identical to endogenously produced growth hormone. Researchers investigating growth factor signalling pathways, protein synthesis mechanisms, and metabolic regulation frequently examine this compound in controlled laboratory environments. The 150 IU formulation provides substantial material for extended research protocols and dose-response studies across multiple experimental conditions.
Laboratory Applications
Research scientists utilise Somatropin 191aa to investigate growth hormone receptor binding kinetics, IGF-1 pathway activation, and downstream signalling cascades in cellular models. The compound serves as a valuable tool for examining metabolic regulation, lipolysis mechanisms, and protein synthesis pathways in laboratory settings. Studies often evaluate its effects on cell proliferation, differentiation, and apoptosis across various tissue types. Researchers at Stroid UK Shop can access this compound alongside comprehensive growth hormone research materials for comparative studies. Additionally, investigators frequently combine these studies with selective androgen receptor modulators and peptide compounds to examine complex hormonal interactions in research models.
Technical Specifications
| Parameter | Specification |
|---|---|
| Sequence Length | 191 amino acids |
| Activity | 150 International Units |
| Manufacturer | CanadaBioLabs |
| Form | Lyophilised powder |
| Storage Temperature | 2-8°C refrigerated |
| Reconstitution | Sterile bacteriostatic water |
| Molecular Weight | 22,124 Da |
| Stability | Verify with supplier documentation |
Research Compliance
This Somatropin 191aa preparation is manufactured exclusively for in-vitro laboratory research applications. The compound requires proper laboratory protocols, appropriate storage conditions, and qualified research personnel for handling. Investigators must maintain detailed research documentation and follow institutional biosafety guidelines when working with growth hormone compounds. All research activities should comply with relevant laboratory safety standards and institutional review protocols for biological research materials.
